Zimmer Biomet Holdings, Inc. Stock price

Equities

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-03-18 pm EDT 5-day change 1st Jan Change
126 USD +0.63% Intraday chart for Zimmer Biomet Holdings, Inc. -1.62% +3.50%
Sales 2024 * 7.74B Sales 2025 * 8.1B Capitalization 25.83B
Net income 2024 * 1.05B Net income 2025 * 1.2B EV / Sales 2024 * 3.84 x
Net Debt 2024 * 3.91B Net Debt 2025 * 2.61B EV / Sales 2025 * 3.51 x
P/E ratio 2024 *
24.1 x
P/E ratio 2025 *
21.4 x
Employees 18,000
Yield 2024 *
0.77%
Yield 2025 *
0.83%
Free-Float 64.89%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.63%
1 week-0.62%
Current month+1.29%
1 month+1.00%
3 months+6.13%
6 months+3.83%
Current year+3.50%
More quotes
1 week
124.38
Extreme 124.38
128.47
1 month
122.49
Extreme 122.49
129.52
Current year
119.13
Extreme 119.13
129.52
1 year
102.00
Extreme 102
149.25
3 years
100.39
Extreme 100.39
180.36
5 years
74.37
Extreme 74.37
180.36
10 years
74.37
Extreme 74.37
180.36
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 18-10-31
Director of Finance/CFO 55 19-06-30
Chief Tech/Sci/R&D Officer - 21-06-06
Members of the board TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 68 08-12-31
Director/Board Member 51 14-12-11
More insiders
Date Price Change Volume
24-03-18 126 +0.63% 972,376
24-03-15 125.2 -0.45% 2,672,395
24-03-14 125.7 -0.68% 1,203,903
24-03-13 126.6 -1.26% 846,962
24-03-12 128.2 +0.13% 1,072,974

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
126 USD
Average target price
136.6 USD
Spread / Average Target
+8.47%
Consensus
  1. Stock
  2. Equities
  3. Stock Zimmer Biomet Holdings, Inc. - Nyse